SCHEMBL5577286

SCHEMBL5577286

COc1ccc(C(=O)NCc2cccc(C3CCN(Cc4ccccc4Cl)CC3)c2)c(OC)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.51
GAA P10253 1/20 0.51
PKM P14618 1/20 0.51
HPGD P15428 1/20 0.51
HTT P42858 1/20 0.51
CXCR4 P61073 2/20 0.49
CHRM4 P08173 1/20 0.49
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
DRD2 P14416 4/20 0.47
DRD4 P21917 3/20 0.47
SIGMAR1 Q99720 2/20 0.47
TP53 P04637 1/20 0.47
ALPL P05186 1/20 0.47
ALPI P09923 1/20 0.47
ALPG P10696 1/20 0.47
MAPT P10636 2/20 0.46
CHRM3 P20309 1/20 0.46
DRD3 P35462 2/20 0.46
CCR3 P51677 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5577776 0.89 MAPT (0.55) HTTCHRM4MEN1KMT2ADRD2
SCHEMBL5577259 0.82 MAPT (0.45) ALDH1A1GAAPKMHPGDHTT
SCHEMBL5577306 0.79 MAPT (0.44) ALDH1A1GAAPKMHPGDHTT
SCHEMBL5577414 0.78 CHRM3 (0.48) ALDH1A1GAACHRM4MEN1KMT2A
SCHEMBL5577662 0.78 CXCR4 (0.55) ALDH1A1GAACXCR4CHRM4MEN1
SCHEMBL5577586 0.77 ACKR3 (0.53) CXCR4DRD2
SCHEMBL5577667 0.77 PTBP1 (0.51) ALDH1A1GAAPKMHPGDHTT
SCHEMBL5577786 0.76 MEN1 (0.50) ALDH1A1CHRM4MEN1KMT2ADRD2
SCHEMBL5577301 0.76 ALDH1A1 (0.51) ALDH1A1GAAPKMHPGDHTT
SCHEMBL5577724 0.75 ACKR3 (0.50) ALDH1A1HPGDHTTCXCR4CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-02-22 US disclosed
EP-1616862-A1 NITROGENOUS HETEROCYCLIC COMPOUND AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-01-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof HLA-DRB1, MIF, HLA-C ALDH1A1 1147/4885GAA 3806/4885PKM 2704/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.